Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- ChecktodayChange DetectedA new revision entry (v3.6.2) was added to the record history, and the earlier entry (v3.6.0) was removed, indicating a minor backend update to the page history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecruitment status updated to no longer look for participants. The study record was revised to version 3.6.0, replacing the previous 3.5.5 version.SummaryDifference0.3%

- Check22 days agoChange DetectedA new version entry (v3.5.5) was added on 2026-06-04, introducing updated Study Status and Contacts/Locations sections; the previous revision (v3.5.4) was removed on 2026-04-14.SummaryDifference0.4%

- Check43 days agoChange DetectedA new revision label v3.5.4 appears in the record history, replacing the previous v3.5.3. This reflects an internal update to the page rendering rather than any change to trial data or user-facing content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a new build of the ClinicalTrials.gov history view. This update is a metadata/version change and does not alter study data, records, or user-facing functionality.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the version history, updating the record with current recruitment status and location details. The revision is v3.5.2.SummaryDifference0.4%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.